By Associate Professor Suzanne Jean Hodgkinson

Journal articles

Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM, 2012, 'IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.', Blood, 119, pp. 4441 - 4450, http://dx.doi.org/10.1182/blood-2011-12-396101

Ghia D; Thomas P; Cordato D; Epstein D; Beran RG; Cappelen-Smith C; Griffith N; Hanna I; McDougall A; Hodgkinson SJ; Worthington JM, 2012, 'Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney Transient Ischaemic Attack Study', INTERNAL MEDICINE JOURNAL, 42, pp. 913 - 918, http://dx.doi.org/10.1111/j.1445-5994.2011.02564.x

Lee KFE; Lu B; Roussel JC; Murray-Segal LJ; Salvaris EJ; Hodgkinson SJ; Hall BM; d'Apice AJF; Cowan PJ; Gock H, 2012, 'Protective Effects of Transgenic Human Endothelial Protein C Receptor Expression in Murine Models of Transplantation', AMERICAN JOURNAL OF TRANSPLANTATION, 12, pp. 2363 - 2372, http://dx.doi.org/10.1111/j.1600-6143.2012.04122.x

Tran T; Hodgkinson S; Carter N; Verma N; Plain K; Nomura M; Robinson C; Killingsworth M; Boyd R; Hall B, 2011, 'Antigen specific CD4+CD25+Tregs promoted by IL-5 and IL-4 prevented demyelination', MULTIPLE SCLEROSIS JOURNAL, 17, pp. S430 - S430, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137301318&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tran G; Hodgkinson S; Carter N; Verma N; Robinson C; Plain K; Boyd R; Hall B, 2011, 'Induction of antigen specific CD4+CD25+T regulatory cells in vitro that control demyelination in autoimmune disease', MULTIPLE SCLEROSIS JOURNAL, 17, pp. S205 - S205, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137300412&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Khatri B; Barkhof F; Comi G; Hartung H-P; Kappos L; Montalban X; Pelletier J; Stites T; Wu S; Holdbrook F; Zhang-Auberson L; Francis G; Cohen JA; Group OBOTTS, 2011, 'Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study', The Lancet Neurology, 10, pp. 520 - 529, http://dx.doi.org/10.1016/s1474-4422(11)70099-0

Hall BM; Verma ND; Tran GT; Hodgkinson SJ, 2011, 'Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.', Curr Opin Immunol, 23, pp. 641 - 647, http://dx.doi.org/10.1016/j.coi.2011.07.012

Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM, 2010, 'Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.', J Neuroimmunol, 229, pp. 98 - 106, http://dx.doi.org/10.1016/j.jneuroim.2010.07.010

Ghia D; Thomas PR; Cordato DJ; Worthington JM; Cappelen-Smith C; Griffith N; Hanna I; Hodgkinson SJ; McDougall A; Beran RG, 2010, 'Validation of emergency and final diagnosis coding in transient ischemic attack: South Western Sydney transient ischemic attack study', Neuroepidemiology, 35, pp. 53 - 58, http://dx.doi.org/10.1159/000310338

Wang C; Tay SS; Tran GT; Hodgkinson SJ; Allen RDM; Hall BM; McCaughan GW; Sharland AF; Bishop GA, 2010, 'Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.', Transpl Immunol, 22, pp. 172 - 178, http://dx.doi.org/10.1016/j.trim.2009.11.005

Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM, 2009, 'CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.', Blood, 113, pp. 479 - 487, http://dx.doi.org/10.1182/blood-2008-05-156612

Hall BM; Tran G; Hodgkinson SJ, 2009, 'Alloantigen specific T regulatory cells in transplant tolerance.', Int Immunopharmacol, 9, pp. 570 - 574, http://dx.doi.org/10.1016/j.intimp.2009.01.016

Cordato DJ; Thomas PC; Ghia D; Taneja S; Worthington JM; Mcdougall AJ; Hodgkinson SJ; Hanna IY; Griffith N; Cappelen-Smith C; Beran RG, 2009, 'Decreasing presentations of seizures to emergency departments in a large Australian population', Epilepsy and Behavior, 16, pp. 475 - 478, http://dx.doi.org/10.1016/j.yebeh.2009.08.027

Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD, 2009, 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis', PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 82, pp. 41 - 56, http://dx.doi.org/10.1348/147608308X345614

Verma ND; Plain KM; Nomura M; Tran GT; Boyd R; Carter N; Robinson C; Wang C; Bishop GA; Hodgkinson SJ; Hall BM, 2008, '+CD25+FOXP3+T ALLOANTIGEN ACTIVATED NAIVE CD4 REGULATORY CELLS EXPRESS CD8; A MARKER OF NEWLY ACTIVATED ANTIGEN SPECIFIC T REGULATORY CELLS', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331421.48421.97

Hall B; Plain K; Nomura M; Verma N; Tran G; Boyd R; Robinson C; Hodgkinson S, 2008, 'ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERLEUKIN-5 (IL-5), NOT IL-4.', Transplantation, 86, pp. 136 - 136, http://dx.doi.org/10.1097/01.tp.0000332495.28926.ce

Verma ND; Plain KM; Nomura M; Robinson C; Tran GT; Boyd R; Hodgkinson SJ; Hall BM, 2008, 'ANTIGEN SPECIFIC T REGULATORY CELLS FROM TOLERANT HOSTS EXHIBIT PHENOTYPES SIMILAR TO CELLS THAT WERE ACTIVATED IN VITRO AND USED TO INDUCE TOLERANCE', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331422.56045.85

Plain K; Verma N; Robinson C; Tran G; Boyd R; Hodgkinson S; Hall B, 2008, 'IL-4 HAS TOLEROGENIC AND ALLOGENIC EFFECTS: IT ACTIVATES CD4+CD25+ T CELLS TO INDUCE SPECIFIC TRANSPLANT TOLERANCE AND PROMOTES REJECTION, EFFECTING CD4+CD25-T CELLS TO EXPRESS CD25 BUT NOT FOXP3.', Transplantation, 86, pp. 513 - 514, http://dx.doi.org/10.1097/01.tp.0000331185.87776.58

Kehdi EE; Cordato DJ; Thomas PR; Beran RG; Cappelen-Smith C; Griffith NC; Hanna IY; McDougall AJ; Worthington JM; Hodgkinson SJ, 2008, 'Outcomes of patients with transient ischaemic attack after hospital admission or discharge from the emergency department', MEDICAL JOURNAL OF AUSTRALIA, 189, pp. 9 - 12, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01886.x

Lam V; Taylor CF; Laurence JM; Wang C; Sharland A; McCaughan G; Hodgkinson SJ; Allen R; Hall BM; Bishop A, 2008, 'Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: Effect on foxp3 and cytokine expression and graft infiltration', Transplant Immunology, 19, pp. 20 - 24, http://dx.doi.org/10.1016/j.trim.2008.01.002

Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ, 2008, 'Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.', Transpl Immunol, 18, pp. 291 - 301, http://dx.doi.org/10.1016/j.trim.2007.09.002

Richards A; Van Den Maagdenberg AMJM; Jen JC; Kavanagh D; Bertram P; Spitzer D; Liszewski MK; Barilla-Labarca ML; Terwindt GM; Kasai Y; McLellan M; Grand MG; Vanmolkot KRJ; De Vries B; Wan J; Kane MJ; Mamsa H; Schäfer R; Stam AH; Haan J; De Jong PTVM; Storimans CW; Van Schooneveld MJ; Oosterhuis JA; Gschwendter A; Dichgans M; Kotschet KE; Hodgkinson S; Hardy TA; Delatycki MB; Hajj-Ali RA; Kothari PH; Nelson SF; Frants RR; Baloh RW; Ferrari MD; Atkinson JP, 2007, 'C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy', Nature Genetics, 39, pp. 1068 - 1070, http://dx.doi.org/10.1038/ng2082

Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM, 2007, 'Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.', J Immunol, 179, pp. 172 - 178, http://dx.doi.org/10.4049/jimmunol.179.1.172

Hall BM; Plain KM; Verma ND; Tran GT; Boyd R; Robinson CM; Nicolls MR; Berger ME; Nomura M; Hodgkinson SJ, 2007, 'Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens.', Transplantation, 83, pp. 1075 - 1084, http://dx.doi.org/10.1097/01.tp.0000259553.66185.2f

Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.', Transplantation, 83, pp. 764 - 773, http://dx.doi.org/10.1097/01.tp.0000256326.11647.2e

Hodgkinson SJ; Sedal L; Paine M; Seijka S; Butzkueven H; Booth D; Mackay F; Tabensky A, 2007, '317: Developing strategies to manage neutralising antibodies – preliminary results from the RENeu study and some individual case reports', Journal of Clinical Neuroscience, 14, pp. 1013 - 1014, http://dx.doi.org/10.1016/j.jocn.2007.02.023

Davidson C; Verma ND; Robinson CM; Plain KM; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation.', Transpl Immunol, 17, pp. 178 - 186, http://dx.doi.org/10.1016/j.trim.2006.09.035

Hodgkinson S; Sedal L; Paine M; Siejka S; Gorai D; Butzkueven H; Willoughby E; Boundy K; Booth D; Mackay F; Tabensky A; Sartori L; Curnow K; Paine M, 2006, 'Developing strategies to manage neutralising antibodies - preliminary results from the RENeu study', MULTIPLE SCLEROSIS, 12, pp. S203 - S204, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400668&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brown RF; Tennant CC; Sharrock M; Hodgkinson S; Dunn SM; Pollard JD, 2006, 'Relationship between stress and relapse in multiple sclerosis: Part I. Important features', Multiple Sclerosis, 12, pp. 453 - 464, http://dx.doi.org/10.1191/1352458506ms1295oa

Brown RF; Tennant CC; Sharrock M; Hodgkinson S; Dunn SM; Pollard JM, 2006, 'Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships', Multiple Sclerosis, 12, pp. 465 - 475, http://dx.doi.org/10.1191/1352458506ms1296oa

Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM, 2006, 'The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4(+)CD25(+) T cells/CD4(+)CD25(-) T cells determines', TRANSPLANT IMMUNOLOGY, 15, pp. 311 - 318, http://dx.doi.org/10.1016/j.trim.2006.01.003

Wang C; Li J; Cordoba SP; McLeod DJ; Tran GT; Hodgkinson SJ; Hall BM; McCaughan GW; Bishop GA, 2005, 'Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection.', Transplantation, 79, pp. 1116 - 1120, http://dx.doi.org/10.1097/01.tp.0000161249.20922.16

Levi CR; Blacker DJ; Bladin CF; Boers PM; Chambers BR; Chu LL; Corbett AJ; Crimmins DS; Davis SM; Donnan GA; Dunbabin DW; Fink JN; Frayne JH; Gerraty RP; Hankey GJ; Hodgkinson SJ; Hughes JT; Ingall TJ; Landau PB; Lindley RI; Long PW; Markus R; Mullins EM; Parsons MW; Pollack MRP; Read SJ; Rosen DM; Schultz DW; Serisier DE; Watson JDG; Storey CE; Zagami AA, 2004, 'Tissue plasminogen activator (tPA) in acute ischaemic stroke: Time for collegiate communication and consensus', Medical Journal of Australia, 180, pp. 634 - 636, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06127.x

Bishop GA; Li J; Trang G; Hodgkinson SJ; Hall BM; McCaughan GW; Allen RDM; Wang C, 2004, 'POST-TRANSPLANT IL-4 TREATMENT CONVERTS RAT LIVER ALLOGRAFT TOLERANCE TO REJECTION', Transplantation, 78, pp. 153 - 153, http://dx.doi.org/10.1097/00007890-200407271-00404

Tran GT; Hodgkinson SJ; Carter N; Killingsworth M; Spicer ST; Hall BM, 2002, 'Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords', JOURNAL OF IMMUNOLOGY, 168, pp. 4293 - 4300, http://dx.doi.org/10.4049/jimmunol.168.9.4293

Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran G; Penny MJ; Hodgkinson SJ; Hall BM, 2001, 'Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.', J Immunol, 167, pp. 3725 - 3733, http://dx.doi.org/10.4049/jimmunol.167.7.3725

Hodgkinson SJ, 2001, 'Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?', Journal of Clinical Neuroscience, 8, pp. 378 - 379, http://dx.doi.org/10.1054/jocn.2001.0911

Tran GT; Carter N; Hodgkinson SJ, 2001, 'Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.', Int Immunopharmacol, 1, pp. 1709 - 1723, http://dx.doi.org/10.1016/s1567-5769(01)00081-9

Tran GT; Carter N; He XY; Spicer TS; Plain KM; Nicolls M; Hall BM; Hodgkinson SJ, 2001, 'Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4.', Int Immunol, 13, pp. 1109 - 1120, http://dx.doi.org/10.1093/intimm/13.9.1109

Hall BM; Hodgkinson SJ; Quin J, 1999, 'Corticosteroids in autoimmune diseases', Australian Prescriber, 22, pp. 9 - 11

Hall BM; Hodgkinson SJ; Quin JW, 1999, 'Corticosteroids in Autoimmunity', Australian Prescriber, pp. 15 - 18

Van Oosten BW; Lai M; Hodgkinson S; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Rudge P; McDougall A; McLeod JG; Adèr HJ; Polman CH, 1997, 'Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled, MR- monitored phase II trial', Neurology, 49, pp. 351 - 357, http://dx.doi.org/10.1212/WNL.49.2.351

Murwani R; Hodgkinson S; Armati P, 1996, 'Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation', Journal of Neuroimmunology, 71, pp. 65 - 71, http://dx.doi.org/10.1016/S0165-5728(96)00131-2

Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J, 1996, 'Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis', Annals of Neurology, 39, pp. 6 - 16, http://dx.doi.org/10.1002/ana.410390104

Van Oosten BW; Lai M; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Hodgkinson S; Polman CH, 1996, 'A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis', Multiple Sclerosis, 1, pp. 339 - 342, http://dx.doi.org/10.1177/135245859600100611

Barkhof F; Thompson AJ; Hodgkinson S; van Oosten B; Lai M; Polman CH; McLeod J; Rudge P; Moseley IF; Ader H; Miller DH, 1995, 'Double-blind, placebo-controlled, MR monitored exploratory trial of chimeric anti-CD4 antibodies in MS.', Journal of Neuroimmunology, 56-63, pp. 15 - 15, http://dx.doi.org/10.1016/0165-5728(95)98902-n

Lindsey JW; Hodgkinson S; Mehta R; Siegel RC; Mitchell DJ; Lim M; Piercy C; Tram T; Dorfman L; Enzmann D; Steinman L, 1994, 'Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis', Neurology, 44, pp. 413 - 419, http://dx.doi.org/10.1212/wnl.44.3_part_1.413

Lindsey RJW; Hodgkinson S; Mehta R; Mitchell D; Enzmann D; Steinman L, 1994, 'Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis', Annals of Neurology, 36, pp. 183 - 189, http://dx.doi.org/10.1002/ana.410360210

Hodgkinson SJ; Westland KW; Pollard JD, 1994, 'Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes', Journal of the Neurological Sciences, 123, pp. 162 - 172, http://dx.doi.org/10.1016/0022-510X(94)90219-4

Bell RB; Lindsey JW; Sobel RA; Hodgkinson S; Steinman L, 1993, 'Diverse T cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis', Journal of Immunology, 150, pp. 4085 - 4092

Back to profile page